Second, AIFCM can also reverse multidrug resistance by regulating the expression of ABC transporters and multiple signaling pathways such as Bcl-2, NF-κB, and PI3K, thus sensitizing the tumor to chemotherapeutic drugs, reducing the side effects, and improving the efficacy of chemotherapy. Here, BCL2 is linked to neoplasm.